Tierney David S

CIK 00012926365 companiesCORAL GABLES, FL

SEC Profile

Transactions

Companies

Filings

CIK

0001292636

Recent Transactions

50 trades

Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2025-12-08−1,413→ 179,497 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2025-12-08+1,413→ 381,980 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2025-11-21+947→ 380,567 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2025-11-21−947→ 180,910 total
Award
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2025-11-20+5,468→ 181,857 total
Award
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2025-11-20+18,115→ 176,389 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2025-08-27$2.24/sh+50,000→ 405,620 total
Sale
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2025-08-27$20.20/sh−26,000→ 379,620 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2025-08-27−50,000→ 158,274 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2025-02-14+4,000→ 355,620 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2025-02-14−4,000→ 208,274 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2024-12-27+1,333→ 351,620 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2024-12-27−1,333→ 212,274 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2024-12-09+1,413→ 350,287 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2024-12-09−1,413→ 213,607 total
Award
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2024-11-21+23,248→ 212,179 total
Award
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2024-11-21+2,841→ 215,020 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2024-08-22+15,000→ 188,931 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2024-08-21$4.01/sh+15,000→ 363,874 total
Sale
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2024-08-21$20.10/sh−15,000→ 348,874 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2024-04-08+25,000→ 203,931 total
Sale
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2024-04-08$15.68/sh−25,000→ 348,874 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2024-04-08$4.01/sh+25,000→ 373,874 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2024-02-15−4,000→ 228,931 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, Par Value $0.001 per share
2024-02-15+4,000→ 348,874 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2024-01-02−10,000→ 232,931 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, Par Value $0.001 per share
2024-01-02$1.13/sh+10,000→ 344,874 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, Par Value $0.001 per share
2023-12-27+1,333→ 334,874 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2023-12-27−1,333→ 242,931 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2023-12-12$1.13/sh+50,000→ 383,541 total
Sale
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2023-12-12$13.32/sh−50,000→ 333,541 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2023-12-12+50,000→ 244,264 total
Award
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2023-12-08+29,524→ 290,024 total
Award
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2023-12-08+4,240→ 294,264 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2023-05-11−20,000→ 260,500 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2023-05-11$0.79/sh+20,000→ 333,541 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2023-04-05−30,000→ 280,500 total
Sale
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2023-04-05$16.83/sh−30,000→ 313,541 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2023-04-05$0.79/sh+30,000→ 343,541 total
Purchase
ZEVRA THERAPEUTICS, INC.$ZVRA
Common Stock
2023-03-09$4.15/sh+5,000→ 10,835 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, Par Value $0.001 per share
2023-02-15+4,000→ 313,541 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2023-02-15−4,000→ 310,500 total
Award
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2022-12-27+15,000→ 310,500 total
Award
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2022-12-27+4,000→ 314,500 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2022-12-06−1,334→ 295,500 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, Par Value $0.001 per share
2022-12-06+1,334→ 309,541 total
Sale
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2022-08-22$14.16/sh−20,000→ 308,207 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2022-08-22$2.53/sh+20,000→ 328,207 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2022-08-22−20,000→ 296,834 total
Award
ZEVRA THERAPEUTICS, INC.$ZVRA
Stock Option (right to buy)
2022-06-28+15,000→ 15,000 total

Companies

Recent Filings

Address

335 ALHAMBRA CIRCLE SUITE 1370

CORAL GABLES, FL, 33134

View on SEC.gov